PH Research, S.L.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer (NCT03481920) | PH Research, S.L. | 2018-01-10 |
Track PH Research, S.L. automatically
Every clearance here is in the API, with alerts when new ones post.